Responsiveness of epigenetic aging biomarkers to longevity interventions in humans
First systematic test of whether DNA-methylation clocks behave as surrogate endpoints should. Clocks trained on mortality or pace of aging responded most strongly and most consistently with one another; pharmacological and lifestyle interventions produced the largest biomarker movement; and study population and duration were decisive determinants of detectable response. Multi-subscore 'explainable' clocks gave greater mechanistic specificity than single-score clocks.
Evidence
8/10
Strong Evidence
Sample
—
subjects
Duration
Varied; pooled across 51 longitudinal interventional studies
study period
Journal
Nature Medicine
Aug 2026
Full Abstract
Aging biomarkers can potentially allow researchers to rapidly monitor the impact of an aging intervention without the need for decade-spanning trials. However, before the use of aging biomarkers, such as epigenetic clocks, as surrogate endpoints, their responsiveness to interventions that target aging must be tested. Here we curate TranslAGE, a harmonized database of 51 public and private longitudinal interventional studies, and calculate a consistent set of 16 prominent epigenetic clocks for each study, along with 94 other DNA methylation (DNAm) biomarkers that can help explain the changes observed for each clock. Using this database, we discover patterns of responsiveness across a variety of interventions and DNAm biomarkers.
Key Findings
- 01
Mortality- and pace-of-aging-trained clocks (generation 2+, reliability-optimized) showed the highest responsiveness and the most agreement with each other
- 02
First-generation chronological-age predictors were substantially less responsive to interventions
- 03
Pharmacological and lifestyle interventions drove the strongest DNAm biomarker responses
- 04
Study population characteristics and study duration were key determinants of whether any response was detectable
- 05
Explainable multi-subscore clocks provided mechanistic specificity that single-score clocks did not
- 06
Implication: clock choice is not interchangeable and a single composite biological-age number is the wrong unit of inference
Structured Methods
- Study Design
- Meta-Analysis
- Sample Size
- Not reported
- Study Duration
- Varied; pooled across 51 longitudinal interventional studies
- Methodology
- Curation of TranslAGE, a harmonized database of 51 public and private longitudinal interventional studies with DNA methylation data; consistent computation of 16 prominent epigenetic clocks plus 94 additional DNAm biomarkers across all studies; systematic comparison of responsiveness patterns by clock generation, intervention class, population and duration.
- Limitations
- Aggregates heterogeneous studies with differing designs, durations and populations; responsiveness is not the same as validated surrogacy for clinical outcomes; no clock met full surrogate-endpoint criteria; accompanying News & Views author discloses GrimAge/PhenoAge patent interests and Altos Labs equity.
Citations & References
Raghav Sehgal, Daniel Borrus, Albert Higgins-Chen (2026). Responsiveness of epigenetic aging biomarkers to longevity interventions in humans. Nature Medicine. https://doi.org/10.1038/s41591-026-04562-9
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation
